These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31470444)

  • 1. Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study.
    Franchi F; Rollini F; Garcia E; Rivas Rios J; Rivas A; Agarwal M; Kureti M; Nagaraju D; Wali M; Briceno M; Moon JY; Kairouz V; Yaranov D; Been L; Suryadevara S; Soffer D; Zenni MM; Bass TA; Angiolillo DJ
    Thromb Haemost; 2020 Jan; 120(1):83-93. PubMed ID: 31470444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled study.
    Franchi F; Rollini F; Cho JR; King R; Phoenix F; Bhatti M; DeGroat C; Tello-Montoliu A; Zenni MM; Guzman LA; Bass TA; Ajjan RA; Angiolillo DJ
    Thromb Haemost; 2016 Mar; 115(3):622-31. PubMed ID: 26633836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.
    Ortega-Paz L; Franchi F; Rollini F; Galli M; Been L; Ghanem G; Shalhoub A; Ossi T; Rivas A; Zhou X; Pineda AM; Suryadevara S; Soffer D; Zenni MM; Jennings LK; Angiolillo DJ
    Thromb Haemost; 2024 Mar; 124(3):263-273. PubMed ID: 37224883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel.
    Ueno M; Ferreiro JL; Tomasello SD; Tello-Montoliu A; Capodanno D; Seecheran N; Kodali M; Dharmashankar K; Desai B; Charlton RK; Bass TA; Angiolillo DJ
    JACC Cardiovasc Interv; 2011 Aug; 4(8):905-12. PubMed ID: 21851906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High glycated albumin is an independent predictor of low response to clopidogrel in ACS patients: a cross-sectional study.
    Zhao X; Li Q; Tu C; Zeng Y; Ye Y
    Cardiovasc Diabetol; 2020 Oct; 19(1):171. PubMed ID: 33036613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual Antiplatelet Therapy Is Associated With Coagulopathy Detectable by Thrombelastography in Acute Stroke.
    McDonald MM; Almaghrabi TS; Saenz DM; Cai C; Rahbar MH; Choi HA; Lee K; Grotta JC; Chang TR
    J Intensive Care Med; 2020 Jan; 35(1):68-73. PubMed ID: 28931362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy.
    Galli M; Franchi F; Rollini F; Been L; Jaoude PA; Rivas A; Zhou X; Jia S; Maaliki N; Lee CH; Pineda AM; Suryadevara S; Soffer D; Zenni MM; Geisler T; Jennings LK; Bass TA; Angiolillo DJ
    Eur Heart J Cardiovasc Pharmacother; 2022 Sep; 8(7):728-737. PubMed ID: 35353154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic effects of a new fixed-dose clopidogrel-aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial.
    Koh JS; Park Y; Tantry US; Ahn JH; Kang MG; Kim K; Jang JY; Park HW; Park JR; Hwang SJ; Kwak CH; Hwang JY; Gurbel PA; Jeong YH
    Platelets; 2017 Mar; 28(2):187-193. PubMed ID: 27560946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of arterial thrombosis by edoxaban, an oral factor Xa inhibitor in rats: monotherapy and in combination with antiplatelet agents.
    Honda Y; Kamisato C; Morishima Y
    Eur J Pharmacol; 2016 Sep; 786():246-252. PubMed ID: 27288116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery.
    Qu J; Zhang H; Rao C; Chen S; Zhao Y; Sun H; Song Y; Liu S; Wang L; Feng W; Wang S; Hu S; Zheng Z
    J Am Heart Assoc; 2021 Jun; 10(11):e020413. PubMed ID: 33998246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.
    Hahn JY; Song YB; Oh JH; Chun WJ; Park YH; Jang WJ; Im ES; Jeong JO; Cho BR; Oh SK; Yun KH; Cho DK; Lee JY; Koh YY; Bae JW; Choi JW; Lee WS; Yoon HJ; Lee SU; Cho JH; Choi WG; Rha SW; Lee JM; Park TK; Yang JH; Choi JH; Choi SH; Lee SH; Gwon HC;
    JAMA; 2019 Jun; 321(24):2428-2437. PubMed ID: 31237645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of antithrombotic therapy and the rationale and design of the randomized edoxaban in patients with peripheral artery disease (ePAD) trial adding edoxaban or clopidogrel to aspirin after femoropopliteal endovascular intervention.
    Tangelder MJ; Nwachuku CE; Jaff M; Baumgartner I; Duggal A; Adams G; Ansel G; Grosso M; Mercuri M; Shi M; Minar E; Moll FL
    J Endovasc Ther; 2015 Apr; 22(2):261-8. PubMed ID: 25809373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial.
    Moll F; Baumgartner I; Jaff M; Nwachuku C; Tangelder M; Ansel G; Adams G; Zeller T; Rundback J; Grosso M; Lin M; Mercur MF; Minar E;
    J Endovasc Ther; 2018 Apr; 25(2):158-168. PubMed ID: 29552984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of dual antiplatelet therapy prescribed as one-pill versus two-pill regimen. A pooled analysis of individual patient data from the three MR-CAPCIS trials.
    Lim WH; Chae IH; Yoon CH; Choi DJ; Lim SW; Park WJ; Doh JH; Kim SH; Kim MA; Lee SH; Yoon JH; Ahn YK; Hyon MS; Kim KS; Kim YK; Lee HC; Seol SH; Hwang KK; Choi SW; Han KR; Shin ES; Kim SW; Lee BK; Kim HS
    Thromb Haemost; 2016 Jul; 116(1):78-86. PubMed ID: 27029284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of esomeprazole vs famotidine on aspirin/clopidogrel dual therapy after percutaneous coronary intervention.
    Wu Y; Chen C; Luo Y; Yu W; Huang S; Lin D
    Adv Clin Exp Med; 2019 Nov; 28(11):1519-1524. PubMed ID: 31660706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual antiplatelet response during PCI: VerifyNow P2Y12 predicts myocardial necrosis and thromboxane B2 generation confirms wide variation in aspirin response.
    Good RI; McGarrity A; James TE; Miller H; McConnachie A; Goodall AH; Oldroyd KG
    Thromb Res; 2015 Jun; 135(6):1140-6. PubMed ID: 25746368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease.
    Galli M; Franchi F; Rollini F; Been L; Jaoude PA; Rivas A; Zhou X; Jia S; Maaliki N; Lee CH; Pineda AM; Suryadevara S; Soffer D; Zenni MM; Geisler T; Jennings LK; Bass TA; Angiolillo DJ
    Thromb Haemost; 2022 Aug; 122(8):1341-1351. PubMed ID: 34983074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin generation induced by tissue factor plus ADP in human platelet rich plasma: A potential new measurement to assess the effect of the concomitant use of an oral factor Xa inhibitor edoxaban and P2Y12 receptor antagonists.
    Honda Y; Morishima Y
    Thromb Res; 2015 May; 135(5):958-62. PubMed ID: 25791908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of aging on platelet reactivity in diabetic patients receiving dual antiplatelet therapy.
    Verdoia M; Pergolini P; Nardin M; Rolla R; Tonon F; Kedhi E; Suryapranata H; Carriero A; De Luca G;
    J Thromb Thrombolysis; 2019 Oct; 48(3):413-421. PubMed ID: 31065927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin & clopidogrel non-responsiveness & its association with genetic polymorphisms in patients with myocardial infarction.
    Pandey CP; Misra A; Negi MPS; Kanuri BN; Chhonker YS; Bhatta RS; Narain VS; Dikshit M
    Indian J Med Res; 2019 Jul; 150(1):50-61. PubMed ID: 31571629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.